Yung-Chung Sung

The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study

Jaw-Yuan Wang, Jeng-Kai Jiang, H. Tsai, 2023, British Journal of Cancer.